6th Norwegian Cancer Symposium, Oslo, 4 to 6 December, 2017

Detailed program

The program consists of keynotes and lectures by invited scientists, oral presentations based on selected submitted abstracts, as well as poster presentations.

To submit an abstract for oral presentation in the plenary sessions, please create an account and then log in with the supplied password. For further details, please see the information for presenters.

The programme is preliminary as of July 16, 2017 and is subject to change.

Monday 4 December

13.00 Welcome
13.15 Session 1 - Computational cancer genomics
13.15 Keynote: Peter J. Park, Harvard Medical School
14.00 Keynote: Ivo Gut, Centro Nacional de Análisis Genómico (CNAG)
The Pancancer study of the International Cancer Genome Consortium
14.30 Break
15.00 TBA
15.35 Stian Knappskog, University of Bergen
Driver mutations in chemoresistant breast cancer
16.00 Ragnhild Lothe, OUS, The Norwegian Radium hospital
16.25 Gunhild Mælandsmo, OUS, The Norwegian Radium hospital
16.50 Ola Myklebost, University of Bergen
Using genomics and cell biology to find new treatment for orphan cancer
17.10 Break
18.30 City Hall Reception
20.00 End

Tuesday 5 December

09.00 Session 2 - Tumor Immunology and the microenvironment
09.00 Keynote: Ash Alizadeh, Stanford University
Circulating Tumor DNA Analysis for Personalized Cancer Detection and Monitoring
09.45 Break
10.00 TBA
10.40 Els Verdegaal, Leiden University Medical Center
11.10 June Myklebust, OUS, The Norwegian Radium Hospital
Identification of targets for immune checkpoint blockade in B-cell lymphoma
11.35 Trevor Clancy, OUS, The Norwegian Radium Hospital
12.00 Posters
13.00 Lunch
14.15 Session 3 - Single cell analysis for disease trajectories and Liquid Biopsies, monitoring cancer genetics in body fluids
14.15 Keynote: Nitzan Rosenfeld
Liquid biopsies: expanding technologies and clinical applications of circulating tumour DNA
14.55 Sten Jacobsen, University of Oxford
Unraveling the biology of normal and malignant hematopoietic stem cells at the single cell level
15.35 Heidi Namløs, OUS, The Norwegian Radium Hospital
Liquid biospies; A non-invasive insight into the sarcoma genome
15.55 Hilde Langseth, The Norwegian Cancer Registry
miRNA as early detection biomarker of lung cancer
16.15 TBA (from abstract)
16.35 TBA (from abstract)
17.00 Poster session (with drinks/snacks)
19.00 Conference dinner

Wednesday 6 December

09.00 Session 4 - Clinical interpretation to guide precision medicine and diagnostics (translation and clinical genomics). Precision drugs, reality, predictions and combinations and New strategies for “personalized” clinical trials
09.00 Keynote: Ching C. Lau, Connecticut children's medical center 
Development and practice of precision medicine in pediatric oncology
09.45 Break
10.00 Edwin Cuppen, Hartwig medical foundation
National scale tumor whole genome sequencing for personalized cancer treatment
10.40 Bjørn Tore Gjertsen, University of Bergen
11.20 TBA (from abstract)
11.40 TBA (from abstract)
11.55 End

Norsk Hydro's Fund for Cancer Research